Literature DB >> 29750409

Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology.

John E Ripollone1,2, Krista F Huybrechts1,2, Kenneth J Rothman1,3, Ryan E Ferguson1,4, Jessica M Franklin2.   

Abstract

Recent work has demonstrated that propensity score matching may lead to increased covariate imbalance, even with the corresponding decrease in propensity score distance between matched units. The extent to which this paradoxical phenomenon might harm causal inference in real epidemiologic studies has not been explored. We evaluated the effect of this phenomenon using insurance claims data from the Pharmaceutical Assistance Contract for the Elderly (1999-2002) and Medicaid Analytic eXtract (2000-2007) databases in the United States. For each data set, we created several 1:1 propensity-score-matched data sets by manipulating the size of the covariate set used to generate propensity scores, the index exposure prevalence in the prematched data set, and the matching algorithm. We matched all index units, then progressively pruned matched sets in order of decreasing propensity score distance, calculating covariate imbalance after each pruning. Although covariate imbalance sometimes increased after progressive pruning of matched sets, the application of commonly used propensity score calipers for defining an acceptable match stopped pruning near the lowest region of the imbalance trend and resulted in an improvement over the imbalance in the prematched data set. Thus, propensity score matching does not appear to induce increased covariate imbalance when standard propensity score calipers are applied in these types of pharmacoepidemiologic studies.

Mesh:

Year:  2018        PMID: 29750409      PMCID: PMC6118075          DOI: 10.1093/aje/kwy078

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  Optimal multivariate matching before randomization.

Authors:  Robert Greevy; Bo Lu; Jeffrey H Silber; Paul Rosenbaum
Journal:  Biostatistics       Date:  2004-04       Impact factor: 5.899

2.  Channeling bias in the interpretation of drug effects.

Authors:  H Petri; J Urquhart
Journal:  Stat Med       Date:  1991-04       Impact factor: 2.373

3.  Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.

Authors:  M Alan Brookhart; Philip S Wang; Daniel H Solomon; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2006-05       Impact factor: 4.822

4.  Discussion of research using propensity-score matching: comments on 'A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003' by Peter Austin, Statistics in Medicine.

Authors:  Jennifer Hill
Journal:  Stat Med       Date:  2008-05-30       Impact factor: 2.373

5.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

6.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

7.  One-to-many propensity score matching in cohort studies.

Authors:  Jeremy A Rassen; Abhi A Shelat; Jessica Myers; Robert J Glynn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-05       Impact factor: 2.890

8.  Regression modelling strategies for improved prognostic prediction.

Authors:  F E Harrell; K L Lee; R M Califf; D B Pryor; R A Rosati
Journal:  Stat Med       Date:  1984 Apr-Jun       Impact factor: 2.373

9.  Bias associated with using the estimated propensity score as a regression covariate.

Authors:  Erinn M Hade; Bo Lu
Journal:  Stat Med       Date:  2013-06-21       Impact factor: 2.373

10.  Statins and congenital malformations: cohort study.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; Michael A Fischer; Ellen W Seely; Jeffrey L Ecker; Jessica M Franklin; Rishi J Desai; Cora Allen-Coleman; Helen Mogun; Jerry Avorn; Krista F Huybrechts
Journal:  BMJ       Date:  2015-03-17
View more
  11 in total

1.  Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study.

Authors:  Sarah K Chen; Katherine P Liao; Jun Liu; Seoyoung C Kim
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-29       Impact factor: 4.794

2.  Performance of matching methods in studies of rare diseases: a simulation study.

Authors:  Irena Cenzer; W John Boscardin; Karin Berger
Journal:  Intractable Rare Dis Res       Date:  2020-05

3.  Methodological considerations when analysing and interpreting real-world data.

Authors:  Til Stürmer; Tiansheng Wang; Yvonne M Golightly; Alex Keil; Jennifer L Lund; Michele Jonsson Funk
Journal:  Rheumatology (Oxford)       Date:  2020-01-01       Impact factor: 7.580

4.  Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care.

Authors:  Elisabetta Patorno; Ajinkya Pawar; Jessica M Franklin; Mehdi Najafzadeh; Anouk Déruaz-Luyet; Kimberly G Brodovicz; Steven Sambevski; Lily G Bessette; Adrian J Santiago Ortiz; Martin Kulldorff; Sebastian Schneeweiss
Journal:  Circulation       Date:  2019-04-08       Impact factor: 29.690

5.  SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes.

Authors:  Min Zhuo; Julie M Paik; Deborah J Wexler; Joseph V Bonventre; Seoyoung C Kim; Elisabetta Patorno
Journal:  Am J Kidney Dis       Date:  2021-11-08       Impact factor: 11.072

6.  Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.

Authors:  Elisabetta Patorno; Phyo T Htoo; Robert J Glynn; Sebastian Schneeweiss; Deborah J Wexler; Ajinkya Pawar; Lily G Bessette; Kristyn Chin; Brendan M Everett; Seoyoung C Kim
Journal:  Ann Intern Med       Date:  2021-09-28       Impact factor: 25.391

7.  Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients.

Authors:  Aránzazu Caballero-Marcos; Magdalena Salcedo; Roberto Alonso-Fernández; Manuel Rodríguez-Perálvarez; María Olmedo; Javier Graus Morales; Valentín Cuervas-Mons; Alba Cachero; Carmelo Loinaz-Segurola; Mercedes Iñarrairaegui; Lluís Castells; Sonia Pascual; Carmen Vinaixa-Aunés; Rocío González-Grande; Alejandra Otero; Santiago Tomé; Javier Tejedor-Tejada; José María Álamo-Martínez; Luisa González-Diéguez; Flor Nogueras-Lopez; Gerardo Blanco-Fernández; Gema Muñoz-Bartolo; Francisco Javier Bustamante; Emilio Fábrega; Mario Romero-Cristóbal; Rosa Martin-Mateos; Julia Del Rio-Izquierdo; Ana Arias-Milla; Laura Calatayud; Alberto A Marcacuzco-Quinto; Víctor Fernández-Alonso; Concepción Gómez-Gavara; Jordi Colmenero; Patricia Muñoz; José A Pons
Journal:  Am J Transplant       Date:  2021-04-27       Impact factor: 9.369

8.  Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.

Authors:  Elisabetta Patorno; Ajinkya Pawar; Deborah J Wexler; Robert J Glynn; Lily G Bessette; Julie M Paik; Mehdi Najafzadeh; Kimberly G Brodovicz; Anouk Déruaz-Luyet; Sebastian Schneeweiss
Journal:  Diabetes Obes Metab       Date:  2021-12-01       Impact factor: 6.577

9.  Over-the-scope clip vs epinephrine with clip for first-line hemostasis in non-variceal upper gastrointestinal bleeding: a propensity score match analysis.

Authors:  Santi Mangiafico; Flavia Pigò; Helga Bertani; Angelo Caruso; Giuseppe Grande; Costantino Sgamato; Raffaele Manta; Rita Conigliaro
Journal:  Endosc Int Open       Date:  2020-01-08

Review 10.  Matching Methods for Confounder Adjustment: An Addition to the Epidemiologist's Toolbox.

Authors:  Noah Greifer; Elizabeth A Stuart
Journal:  Epidemiol Rev       Date:  2022-01-14       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.